For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment. Treatment of this autoimmune liver disease should also address various symptoms and complications ...
Sorafenib is the standard treatment for patients with advanced ... survival has been demonstrated in patients with Child-Pugh A cirrhosis, information is lacking on the benefits, if any, in ...
This chemopreventive activity became apparent 18-24 months after treatment initiation and increased over time,” the authors wrote. The lack of benefit in patients with established cirrhosis ...